EpiAxis Therapeutics
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
University Of Canberra, Australian Capit...Phone Number
+61 421012268Website
www.epiaxistherapeutics.comRevenue
<$5 MillionIndustry
About EpiAxis Therapeutics
EpiAxis Therapeutics is an investor-focused biotech company that develops reversible cyclic peptide inhibitors of LSD1 to combat treatment resistance in advanced cancers, including prostate, small cell lung, and colorectal cancers. The company aims to unlock the potential of existing therapies through LSD1 inhibition. They offer insights into their scientific research, technology platform, milestones, and collaboration opportunities. EpiAxis Therapeutics is dedicated to rewriting the fate of patients with advanced cancers.Explore more
EpiAxis Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to EpiAxis Therapeutics
Compare insights from companies similar to EpiAxis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
EpiAxis Therapeutics Tech Stack
A closer look at the technologies used by EpiAxis Therapeutics
See more technologies
Top Business Services Companies
Frequently Asked Questions Regarding EpiAxis Therapeutics
Sign Up For FreeTo access detailed company insights
EpiAxis Therapeutics is an investor-focused biotech company that develops reversible cyclic peptide inhibitors of LSD1 to combat treatment resistance in advanced cancers, including prostate, small cell lung, and colorectal cancers. The company aims to unlock the potential of existing therapies through LSD1 inhibition. They offer insights into their... Read More
